[Experiences with Pimafucin in candida and trichomonas vaginitis].
D000935:Antifungal Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007973:Leukorrhea / Q000188:drug therapy; D010866:Natamycin / Q000627:therapeutic use; D013607:Tablets; D014247:Trichomonas Vaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D013607:Tablets; D010866:Natamycin
Erfahrungen mit Pimafucin bei der Candida- und Trichomonaden-Vaginitis.